Progress in cancer gene therapy

Cancer Gene Therapy

Volumn 7, Issue 8, 2000, Pages 1197-1199

  Curiel, David T ^a   Gerritsen, Winald R ^b   Krul, Mark R L ^c  

^a University of Alabama at Birmingham   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NDDO Oncology   (Netherlands)

Author keywords

Clinical trials; Gene therapy; Preclinical research; Replication; Targeting; Vectors

Indexed keywords

GANCICLOVIR; PRODRUG;

CANCER IMMUNOTHERAPY; CANCER RESEARCH; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; GENETIC DISORDER; HEMOPHILIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033845884     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700222     Document Type: Conference Paper

References (12)

1. Second Pasman Keynote Lecture: Gene and oncolytic virus therapies
2. Gene therapy trials show clinical efficacy
3. Adenovirus-mediated in viva gene transfer
4. CAR-independent gene transfer to accomplish efficient, and specific genetic modification of target cells via adenoviral vectors
5. DNA replication-competent natural and recombinant parvoviruses
6. Helper virus-free herpes simplex virus-1 plasmid vectors for therapy of Parkinson's disease and other neurological disorders
7. Reovirus therapy of tumors with activated Ras pathway
8. Viruses as tools for cancer gene therapy: Promises and problems
9. Targeted enzymes for molecular chemotherapy
10. Tumor-selective transcriptional targeting for cancer gene therapy
11. Immunological, pathological, and long-term clinical data of vaccination with autologous granulocyte-macrophage colony-stimulating factor-transduced tumor cells in metastatic melanoma
12. Imaging of herpes simplex virus thymidine kinase (HSV-tk) gene expression with positron emission tomography (PET)